Inovio secures approval to begin Covid-19 vaccine prime-boost trials in China
INO-4800 features a particularly designed deoxyribonucleic acid (DNA) plasmid. To be injected intradermally with subsequent electroporation, INO-4800 carries the DNA plasmid directly into body cells. Inovio’s partner, Advaccine